Serum cystatin C as a biomarker in non-Hodgkin lymphoma and its relationship with paraoxonase 1 activity
Journal of Medical Biochemistry · 2026 · 45 (4) · 889-896
DOI: 10.5937/jomb0-61502 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Biochemistry, 2026. Verfasst von Bosa Mirjanić-Azarić und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Banja Luka, Faculty of Medicine, Department of Medical Biochemistry, Banja Luka, The Republic of Srpska, Bosnia and Herzegovina. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry for Scientific/Technological Development, Higher Education and Information Society, Government of the Republic of Srpska.
Abstract (Originalsprache)
Background
This pilot study aimed to assess the potential of cystatin C (Cys C) as a biomarker in non-Hodgkin lymphoma (NHL) and to explore its association with paraoxonase 1 (PON1) activity.
Methods
The study included 44 patients with B-cell NHL and 44 healthy subjects. Cys C was measured using the Cobas e 801 analyser (Roche Diagnostics GmbH, Mannheim, Germany), while PON1 and TAS were measured on the ILab 300+ system (Instrumentation Laboratory, Milan, Italy).
Results
The serum level of Cys C (mg/L) was significantly higher in NHL patients compared to control subjects: 1.03 (0.88-1.24) vs 0.83 (0.78-0.90), P<0.001. The diagnostic performance of Cys C, as assessed by the area under the ROC curve (AUC), was 0.812 (95% CI: 0.732-0.902). The optimal cut-off value for Cys C was 0.870 mg/L, with sensitivities and specificities of 77.1% and 75.6%, respectively. A significant negative correlation was observed between Cys C and PON1 activity (r=-0.42, P=0.010) in NHL patients.
Conclusion
This study underscores the potential of Cys C as a biomarker in NHL. Notably, in the multivariable analysis, Cys C was the dominant independent predictor of NHL, with each 1 SD increase in Cys C associated with approximately 11-fold higher odds of NHL. Furthermore, the negative correlation between Cys C and PON1, identified for the first time in patients with NHL, may offer valuable insights into the molecular mechanisms underlying this malignancy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Banja Luka, Faculty of Medicine, Department of Medical Biochemistry, Banja Luka, The Republic of Srpska, Bosnia and Herzegovina.
- Aqualab laboratory, Banja Luka, The Republic of Srpska, Bosnia and Herzegovina.
- University Clinical Centre of the Republic of Srpska, Department of Nuclear Medicine, Banja Luka, The Republic of Srpska, Bosnia and Herzegovina.
- University of Banja Luka, Faculty of Medicine, Banja Luka, Republic of Srpska, Bosnia and Herzegovina.
- University Clinical Centre of the Republic of Srpska, Institute of Laboratory Diagnostics, Banja Luka, Republic of Srpska, Bosnia and Herzegovina.
- University of Belgrade, Faculty of Pharmacy, Department of Medical Biochemistry, Belgrade.
Förderung
- Ministry for Scientific/Technological Development, Higher Education and Information Society, Government of the Republic of Srpska
Zitieren
APA
Mirjanić-Azarić, B., Mijić, S., Radić-Savić, Z., Stanković, S., Malčić-Zanić, D., Mihailović, E. N., Stojisavljević, Đ., Ivetić, B., & Bogavac-Stanojević, N. (2026). Serum cystatin C as a biomarker in non-Hodgkin lymphoma and its relationship with paraoxonase 1 activity. Journal of Medical Biochemistry, 45(4), 889-896. https://doi.org/10.5937/jomb0-61502
Vancouver
Mirjanić-Azarić B, Mijić S, Radić-Savić Z, Stanković S, Malčić-Zanić D, Mihailović EN, et al. Serum cystatin C as a biomarker in non-Hodgkin lymphoma and its relationship with paraoxonase 1 activity. Journal of Medical Biochemistry. 2026;45(4):889-896. doi:10.5937/jomb0-61502
BibTeX
@article{MirjaniAzari2026,
author = {Mirjanić-Azarić, Bosa and Mijić, Smiljana and Radić-Savić, Zana and Stanković, Siniša and Malčić-Zanić, Dragana and Mihailović, Egeljić Nataša and Stojisavljević, Đorđe and Ivetić, Bojana and Bogavac-Stanojević, Nataša},
title = {Serum cystatin C as a biomarker in non-Hodgkin lymphoma and its relationship with paraoxonase 1 activity},
journal = {Journal of Medical Biochemistry},
year = {2026},
volume = {45},
number = {4},
pages = {889--896},
doi = {10.5937/jomb0-61502}
}
EUVIMED